Who are we?
For more than 30 years, Stiplastics has been designing, developing and manufacturing medical devices for the healthcare industry.
Our innovative product ranges span dosage systems, pharmaceutical packaging, carrying cases for biological samples, and pillboxes. Stiplastics employs 78 people.
In 2013 Stiplastics made a major shift in its business development strategy under the leadership of a new CEO, Jérôme Empereur, and with the backing of NBGI Private Equity. Today, the company is aggressively pursuing growth on international markets by leveraging its strong reputation among the major pharmaceutical companies, who see in us a reliable, responsive, high-quality partner for developing made-to-measure solutions and innovative projects.
An expert in innovation, Stiplastics draws on the skills of in-house specialists to implement a unique multidisciplinary approach that cuts across :
- plastics engineering and prototyping
- lean manufacturing and GMP
Plastic dosing systems
Our recent acquisitions – an ISO 7 cleanroom, ultra-precise measurement capabilities, and two hectares of additional commercial property to expand our manufacturing capacities – mark a turning point in the company’s history. Now more than ever, we are poised to support our customers as they address exciting – and increasingly demanding – new markets with the level of quality, precision and innovation they have come to expect from Stiplastics.